Literature DB >> 19076140

Assessing the minimum number of lymph nodes needed at radical cystectomy in patients with bladder cancer.

Umberto Capitanio1, Nazareno Suardi, Shahrokh F Shariat, Yair Lotan, Ganesh S Palapattu, Patrick J Bastian, Amit Gupta, Amnon Vazina, Mark Schoenberg, Seth P Lerner, Arthur I Sagalowsky, Pierre I Karakiewicz.   

Abstract

OBJECTIVE: To identify the likelihood of finding one or more positive lymph nodes (LNs) according to the number of LNs removed at radical cystectomy (RC), as the number of LNs removed affects disease progression and survival after RC. PATIENTS AND METHODS: Between 1984 and 2003, 731 assessable patients had RC and bilateral pelvic lymphadenectomy at three different institutions. ROC curve coordinates were used to determine the probability of identifying one or more positive LNs according to the total number of removed LNs.
RESULTS: Of the 731 patients, 174 (23.8%) had LNs metastases. The mean (median, range) number of LNs removed was 18.7 (17, 1-80). The ROC coordinate-based plots of the number of removed LNs and the probability of finding one or more LNs metastases indicated that removing 45 LNs yielded a 90% probability. Conversely, removing either 15 or 25 LNs indicated, respectively, 50% and 75% probability of detecting one or more LNs metastases.
CONCLUSIONS: These data indicate that removing 25 LNs might represent the lowest threshold for the extent of lymphadenectomy at RC. Our findings confirm the importance of an extended lymph node dissection.

Entities:  

Mesh:

Year:  2008        PMID: 19076140     DOI: 10.1111/j.1464-410X.2008.08212.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  16 in total

1.  Variability in surgical quality in a phase III clinical trial of radical cystectomy in patients with organ-confined, node-negative urothelial carcinoma of the bladder.

Authors:  Douglas A Mata; Susan Groshen; Friedrich-Carl Von Rundstedt; Donald G Skinner; Walter M Stadler; Richard J Cote; John P Stein; Seth P Lerner
Journal:  J Surg Oncol       Date:  2015-04-14       Impact factor: 3.454

Review 2.  The role and extent of pelvic lymphadenectomy in the management of patients with invasive urothelial carcinoma.

Authors:  Seth P Lerner
Journal:  Curr Treat Options Oncol       Date:  2009-06-30

Review 3.  The survival benefit of lymph node dissection at the time of removal of kidney, prostate and urothelial carcinomas: what is the evidence?

Authors:  Karim Bensalah; Morgan Roupret; Evanguelos Xylinas; Shahrokh Shariat
Journal:  World J Urol       Date:  2013-04-16       Impact factor: 4.226

Review 4.  Lymph node dissection during radical cystectomy for bladder cancer treatment: considerations on relevance and extent.

Authors:  Lars Weisbach; Roland Dahlem; Giuseppe Simone; Jens Hansen; Armin Soave; Oliver Engel; Felix K Chun; Shahrokh F Shariat; Margit Fisch; Michael Rink
Journal:  Int Urol Nephrol       Date:  2013-07-25       Impact factor: 2.370

Review 5.  Predictive factors of recurrence and survival of upper tract urothelial carcinomas.

Authors:  Grégory Verhoest; Shahrokh F Shariat; Thomas F Chromecki; Jay D Raman; Vitaly Margulis; Giacomo Novara; Christian Seitz; Mesut Remzi; Morgan Rouprêt; Douglas S Scherr; Karim Bensalah
Journal:  World J Urol       Date:  2011-06-17       Impact factor: 4.226

Review 6.  Role of lymph node dissection in management of bladder cancer.

Authors:  Hiroshi Kitamura; Naoya Masumori; Taiji Tsukamoto
Journal:  Int J Clin Oncol       Date:  2011-04-28       Impact factor: 3.402

7.  Clinical and pathological nodal staging score for urothelial carcinoma of the bladder: an external validation.

Authors:  M Gierth; H M Fritsche; H Buchner; M May; A Aziz; W Otto; C Bolenz; L Trojan; E Hermann; A Tiemann; S C Müller; J Ellinger; S Brookman-May; C G Stief; D Tilki; P Nuhn; T Höfner; M Hohenfellner; A Haferkamp; J Roigas; M Zacharias; W F Wieland; H Riedmiller; S Denzinger; P J Bastian; M Burger
Journal:  World J Urol       Date:  2013-06-05       Impact factor: 4.226

Review 8.  Therapeutic role of template-based lymphadenectomy in urothelial carcinoma of the upper urinary tract.

Authors:  Tsunenori Kondo; Toshio Takagi; Kazunari Tanabe
Journal:  World J Clin Oncol       Date:  2015-12-10

9.  Seeking a standard for adequate pathologic lymph node staging in primary bladder carcinoma.

Authors:  Lu Wang; Kumaran Mudaliar; Vikas Mehta; Güliz A Barkan; Marcus L Quek; Robert C Flanigan; Maria M Picken
Journal:  Virchows Arch       Date:  2014-04-04       Impact factor: 4.064

10.  Visceral obesity predicts adverse pathological features in urothelial bladder cancer patients undergoing radical cystectomy: a retrospective cohort study.

Authors:  Francesco Cantiello; Antonio Cicione; Riccardo Autorino; Andrea Salonia; Alberto Briganti; Matteo Ferro; Renato De Domenico; Sisto Perdonà; Rocco Damiano
Journal:  World J Urol       Date:  2013-08-14       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.